MMIT - Managed Markets Insight & Technology

03/06/2026

What you don’t see in patient and provider feedback can cost you. MMIT’s Satisfaction Surveys give you a complete, unbiased view across both audiences, helping you spot gaps, improve faster, and stand out in a crowded market. Explore Satisfaction Surveys. https://vist.ly/56gy7

03/06/2026

https://vist.ly/56fa2 | Payers don’t always respond to a brand’s differentiators as expected. In this study, learn how MMIT’s Message Monitor helped one biopharma company realize that payers were unimpressed with its clinical data, despite its brand’s novel MoA.

Download the case study by clicking on the link in this post.

02/06/2026

https://vist.ly/56cqa | AI is reshaping payer decision-making — even if most providers haven’t noticed yet. Payers representing 45% of commercial lives are already using AI to automate parts of the prior authorization process. And that’s just the beginning.

MMIT’s Jill Linder explores the latest research on payers' use of AI and offers advice on how pharma might rethink its access strategies in response.

01/06/2026

Launching a therapy is more than timing—it’s about reaching the right patients. https://vist.ly/5695g

See how MMIT helped a small biopharma company turn data into confident launch decisions.

Download the case study by clicking on the link in this post.

01/06/2026

Access clarity starts here 💡

Searchlight from MMIT helps pharma teams cut through coverage complexity in rapid time.

Start with the video. If it clicks, the full story is one link away.

▶️ Watch here, then tap through to explore Searchlight. https://vist.ly/5672c

31/05/2026

The first year after launch can define a brand’s long-term trajectory. How quickly are providers adopting your therapy? https://vist.ly/563z5

Are payer restrictions limiting access? Join us on June 22 for a webinar on improving uptake in the first year. Our market access experts will share practical strategies for tracking coverage, influencing payers, and driving prescriptions

30/05/2026

Coverage shouldn’t feel like detective work. 🕵️

By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions.

Clarity changes everything. Illuminate your path with MMIT today. https://vist.ly/5527h

29/05/2026

https://vist.ly/55xrd | AI is reshaping payer decision-making — even if most providers haven’t noticed yet. Payers representing 45% of commercial lives are already using AI to automate parts of the prior authorization process. And that’s just the beginning.

MMIT’s Jill Linder explores the latest research on payers' use of AI and offers advice on how pharma might rethink its access strategies in response.

29/05/2026

Listen to the Pharmacy Podcast Network’s latest episode on Asembia 2026 to hear MMIT’s Andrew Rouff and ’s Hannah Baxter, along with experts from Nested Knowledge, Gifthealth, McKesson, MatchRX, and URAC. https://vist.ly/55x9a

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special. This is part two of ou...

29/05/2026

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside?

With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights.

Meet with MMIT to learn more. Because guessing isn’t a strategy. https://vist.ly/55wx4